(Reuters) – Health Canada will announce the approval of Johnson & Johnson’s single-dose COVID-19 vaccine on Friday, CBC News reported, citing sources.
The vaccine has already been authorized for use in the United States, with an EU decision due this month.
The vaccine was found 66% effective in preventing moderate to severe COVID-19 in a large, global trial.
Health Canada did not immediately respond to a request for comment.
(Reporting by Manas Mishra in Bengaluru; Editing by Vinay Dwivedi)
Maxey and McCain lead the way as Sixers shoot past Nets for much-needed win
Sixers Joel Embiid downgraded to OUT shortly before NBA Cup game
Sixers’ HC Nick Nurse gives mildly positive update on Paul George
When will Phillies’ Zack Wheeler finally win the Cy Young Award?
DeVonta Smith OUT for Eagles vs Rams: Latest injury news
76ers host servicemembers and their families for Thanksgiving dinner
Bowery stabbing leaves one man injured following a dispute: cops
Man stabbed to death in East Harlem rehabilitation center
SEPTA approves 7.5% fare hike starting Dec. 1
DEVELOPING | City of Yes for housing deal takes shape as crucial Thursday council committee vote gets pushed back
